bretylium tosylate has been researched along with amiodarone in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Somberg, J | 1 |
| Huang, SK; Marcus, FI | 1 |
| DiBianco, R; Fletcher, RD; Gottdiener, JS | 1 |
| Somberg, JC | 1 |
| Mohiuddin, SM; Ross, WB | 1 |
| Bexton, RS; Camm, AJ | 1 |
| Harrison, DC; Kates, RE; Keefe, DL | 1 |
| Jalal, S; Naccarelli, GV | 1 |
| Herre, JM; Janosik, DL; Kopelman, HA; Kowey, PR; Levine, JH; Lindsay, BD; Pacifico, A; Plumb, VJ; Scheinman, MM | 1 |
| Grünbaum, L; Hagelüken, A; Harhammer, R; Nürnberg, B; Schunack, W; Seifert, R | 1 |
| Dorian, P | 1 |
5 review(s) available for bretylium tosylate and amiodarone
| Article | Year |
|---|---|
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Dogs; Encainide; Hemodynamics; Humans; Myocardial Contraction; Quinidine; Verapamil | 1982 |
Drugs with a class III antiarrhythmic action.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Bretylium Tosylate; Electrophysiology; Heart Conduction System; Humans; Sotalol | 1982 |
New antiarrhythmic drugs: their place in therapy.
Topics: Action Potentials; Ajmaline; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Tosylate; Disopyramide; Encainide; Hemodynamics; Humans; Kinetics; Moricizine; Morpholines; Phenothiazines; Piperidines; Verapamil | 1981 |
1 trial(s) available for bretylium tosylate and amiodarone
| Article | Year |
|---|---|
Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Bretylium Tosylate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Recurrence; Tachycardia, Ventricular; Time Factors; Ventricular Fibrillation | 1995 |
7 other study(ies) available for bretylium tosylate and amiodarone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
Antiarrhythmic therapy: new additions and future expectations.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Bretylium Tosylate; Disopyramide; Encainide; Humans; Lidocaine; Mexiletine; Tocainide; Verapamil | 1983 |
Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Tosylate; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Randomized Controlled Trials as Topic; Tachycardia, Ventricular; Ventricular Fibrillation | 1995 |
The class III antiarrhythmic drug amiodarone directly activates pertussis toxin-sensitive G proteins.
Topics: Amiodarone; Animals; Bretylium Tosylate; Cattle; Enzyme Activation; GTP Phosphohydrolases; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Humans; Hydrolysis; Pertussis Toxin; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1995 |
[Etiologies of electric storm].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Bretylium Tosylate; Electric Countershock; Female; Hemodynamics; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk Factors; Tachycardia, Ventricular; Ventricular Fibrillation | 1997 |